The MAP3K2 gene in the MAPK pathway, which was regulated by the miRNA markers in PRAD, was previously reported to be associated with the growth and metastasis of prostate tumors (Fulford et al., 2016). Here, MAP3K2 is linked to prostate adenocarcinoma.